116 related articles for article (PubMed ID: 16328663)
21. PDGFRalpha- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features.
Pauls K; Merkelbach-Bruse S; Thal D; Büttner R; Wardelmann E
Histopathology; 2005 Feb; 46(2):166-75. PubMed ID: 15693889
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic targets in gastrointestinal stromal tumors].
Wardelmann E; Schildhaus HU; Merkelbach-Bruse S; Büttner R
Verh Dtsch Ges Pathol; 2006; 90():73-9. PubMed ID: 17867582
[TBL] [Abstract][Full Text] [Related]
23. Comparative ultrastructural analysis and KIT/PDGFRA genotype in 125 gastrointestinal stromal tumors.
Agaram NP; Baren A; Arkun K; Dematteo RP; Besmer P; Antonescu CR
Ultrastruct Pathol; 2006; 30(6):443-52. PubMed ID: 17182437
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
Lasota J; Miettinen M
Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
[TBL] [Abstract][Full Text] [Related]
25. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations.
Agaimy A; Wünsch PH; Hofstaedter F; Blaszyk H; Rümmele P; Gaumann A; Dietmaier W; Hartmann A
Am J Surg Pathol; 2007 Jan; 31(1):113-20. PubMed ID: 17197927
[TBL] [Abstract][Full Text] [Related]
26. Multiple gastrointestinal stromal tumors with a germline c-kit mutation.
Kim HJ; Lim SJ; Park K; Yuh YJ; Jang SJ; Choi J
Pathol Int; 2005 Oct; 55(10):655-9. PubMed ID: 16185297
[TBL] [Abstract][Full Text] [Related]
27. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect.
Agaimy A; Dirnhofer S; Wünsch PH; Terracciano LM; Tornillo L; Bihl MP
Am J Surg Pathol; 2008 Oct; 32(10):1553-9. PubMed ID: 18724245
[TBL] [Abstract][Full Text] [Related]
28. Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate.
Wardelmann E; Merkelbach-Bruse S; Pauls K; Thomas N; Schildhaus HU; Heinicke T; Speidel N; Pietsch T; Buettner R; Pink D; Reichardt P; Hohenberger P
Clin Cancer Res; 2006 Mar; 12(6):1743-9. PubMed ID: 16551858
[TBL] [Abstract][Full Text] [Related]
29. [Activating mutations in receptor tyrosine kinases with relevance for treatment of gastrointestinal stromal tumors].
Wardelmann E; Merkelbach-Bruse S; Büttner R; Schildhaus HU
Verh Dtsch Ges Pathol; 2007; 91():165-8. PubMed ID: 18314611
[TBL] [Abstract][Full Text] [Related]
30. Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations.
Kang HJ; Koh KH; Yang E; You KT; Kim HJ; Paik YK; Kim H
Proteomics; 2006 Feb; 6(4):1151-7. PubMed ID: 16402362
[TBL] [Abstract][Full Text] [Related]
31. Frequency, phenotype, and genotype of minute gastrointestinal stromal tumors in the stomach: an autopsy study.
Muenst S; Thies S; Went P; Tornillo L; Bihl MP; Dirnhofer S
Hum Pathol; 2011 Dec; 42(12):1849-54. PubMed ID: 21658742
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
[TBL] [Abstract][Full Text] [Related]
33. Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital.
Yeh CN; Chen TW; Lee HL; Liu YY; Chao TC; Hwang TL; Jan YY; Chen MF
Ann Surg Oncol; 2007 Mar; 14(3):1123-8. PubMed ID: 17195905
[TBL] [Abstract][Full Text] [Related]
34. Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRA.
Kuroiwa M; Hiwatari M; Hirato J; Suzuki N; Tsuchida Y; Shimada A; Shitara T; Taki T; Hayashi Y
J Pediatr Surg; 2005 Nov; 40(11):1798-801. PubMed ID: 16291174
[TBL] [Abstract][Full Text] [Related]
35. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors.
Daum O; Grossmann P; Vanecek T; Sima R; Mukensnabl P; Michal M
Ann Diagn Pathol; 2007 Feb; 11(1):27-33. PubMed ID: 17240304
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issues.
Reichardt P; Hogendoorn PC; Tamborini E; Loda M; Gronchi A; Poveda A; Schöffski P
Semin Oncol; 2009 Aug; 36(4):290-301. PubMed ID: 19664490
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.
Mussi C; Schildhaus HU; Gronchi A; Wardelmann E; Hohenberger P
Clin Cancer Res; 2008 Jul; 14(14):4550-5. PubMed ID: 18628470
[TBL] [Abstract][Full Text] [Related]
39. c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors.
Miselli FC; Casieri P; Negri T; Orsenigo M; Lagonigro MS; Gronchi A; Fiore M; Casali PG; Bertulli R; Carbone A; Pierotti MA; Tamborini E; Pilotti S
Clin Cancer Res; 2007 Apr; 13(8):2369-77. PubMed ID: 17438095
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
